HeartFlow

Bringing together human ingenuity and advanced technology to help combat heart disease, the #1 cause of death.

HeartFlow’s non-invasive personalized cardiac test provides unprecedented visualization of each patient’s coronary arteries, enabling physicians to create more effective treatment plans for their patients.

At the heart of our mission is a commitment to making cardiovascular care easier for doctors and safer for patients. Physicians get the critical information they need without the added risks and costs of an invasive procedure.

Follow us on Twitter @HeartFlow
Follow us on LinkedIn HeartFlow, Inc.
Visit our website at www.heartflow.com


 

Highlights of the PRECISE Trial to guide management of stable patients with suspected coronary artery disease from Valley Health System

229 views
July 18, 2023

The PRECISE Randomized Controlled Trial is reviewed by Valley Health Hospital System physicians Himanshu Gupta, MD, FACC (Director or Advanced Cardiac Imaging) and Elliot Brown, MD (Director of Cardiac Outreach) highlighting how the study compares strategies associated with diagnosing coronary artery disease.  The CCTA + FFRCT Precision Pathway was superior to traditional testing at 1 year.

Comments 0
Login to view comments. Click here to Login